NCT00107991View on ClinicalTrials.gov

Etanercept for Treatment of Hidradenitis

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

November 30, 2008

Conditions
Hidradenitis Suppurativa
Interventions
DRUG

etanercept

etanercept 50 mg/week subcutaneous injection

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT00107991 - Etanercept for Treatment of Hidradenitis | Biotech Hunter | Biotech Hunter